ARTHUR S. KIRSCH - 20 Feb 2025 Form 3 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Role
Director
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Arthur S. Kirsch
Issuer symbol
AVIR
Transactions as of
20 Feb 2025
Net transactions value
$0
Form type
3
Filing time
24 Feb 2025, 18:47:18 UTC
Previous filing
24 Jun 2024
Next filing
20 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AVIR Common Stock 35,710 20 Feb 2025 Direct
holding AVIR Common Stock 10,000 20 Feb 2025 By trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney